CarrollTP, O'ConnorCA, FloydO, et al.The prevalence of alpha-1 antitrypsin deficiency in Ireland. Respir Res, 2011; 12:91.
2.
ShenS, SanchezME, BlomenkampK, et al.Amelioration of alpha-1 antitrypsin deficiency diseases with genome editing in transgenic mice. Hum Gen Ther, 2018 [Epub ahead of print]; DOI: 10.1089/hum.2017.227.
3.
SongC-Q, WangD, JiangT, et al.In vivo genome editing partially restores alpha1-antitrypsin in a murine model of AAT deficiency. Hum Gene Ther, 2018 [Epub ahead of print]; DOI: 10.1089/hum.2017.225.
4.
BorelF, TangQ, GernouxG, et al.Survival advantage of both human hepatocyte xenografts and genome-edited hepatocytes for treatment of alpha-1 antitrypsin deficiency. Mol Ther, 2017; 25:2477–2489.
